Fund shareholders of COCRYSTAL PHARMA INC
ISIN US19188J4094 · United States · LEI 549300QCJ6RBUJKI7S66
- Fund shareholders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- 459.1K $
- Share of capital
- 2.2 % of 19.3M shares on Aug 13, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 187,266 | 196.6K $ | 0.97 % | as of Jun 30, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 170,962 | 179.5K $ | 0.00 % | 0.89 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 49,807 | 55.8K $ | 0.00 % | 0.26 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 9,629 | 10.8K $ | 0.05 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 8,526 | 9.5K $ | 0.04 % | as of May 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 6,122 | 6.9K $ | 0.03 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 6 | 0 | 432,312 | +36.2 % |
| 2026Q2 | 6 | 0 | 317,422 | +4.8 % |
| 2026Q1 | 6 | -1 | 302,868 | -3.1 % |
| 2025Q4 | 7 | -2 | 312,644 | -9.9 % |
| 2025Q3 | 9 | 0 | 346,960 | -1.1 % |
| 2025Q2 | 9 | -2 | 350,807 | +0.2 % |
| 2025Q1 | 11 | +2 | 350,207 | +0.3 % |
| 2024Q4 | 9 | 0 | 349,121 | +1.0 % |
| 2024Q3 | 9 | +2 | 345,716 | +4.2 % |
| 2024Q2 | 7 | -2 | 331,937 | -0.2 % |
| 2024Q1 | 9 | 0 | 332,502 | -2.7 % |
| 2023Q4 | 9 | 341,640 |
Institutional managers
23 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 123,928 | 125.2K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 90,231 | 91.1K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 73,746 | 74.5K $ | as of Mar 31, 2026 |
| T3 Companies, LLC | 51,500 | 52K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 36,031 | 36.4K $ | as of Mar 31, 2026 |
| NEUBERGER BERMAN GROUP LLC | 31,886 | 32.2K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 20,543 | 20.7K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 15,255 | 15.4K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 13,080 | 13 $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 12,711 | 12.8K $ | as of Mar 31, 2026 |
| Parallel Advisors, LLC | 12,569 | 12.7K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 11,921 | 12K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 7,039 | 7.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 4,644 | 4.7K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 4,248 | 4.3K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 948 | 957 $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 817 | 825 $ | as of Mar 31, 2026 |
| Clean Yield Group | 418 | 422 $ | as of Mar 31, 2026 |
| FMR LLC | 334 | 337 $ | as of Mar 31, 2026 |
| MAI Capital Management | 237 | 240 $ | as of Mar 31, 2026 |
| NVWM, LLC | 84 | 85 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 33 | 33 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 1 $ | as of Mar 31, 2026 |
Declared shareholders of COCRYSTAL PHARMA INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| OPKO HEALTH, INC. and 3 others | 29.60 % | 5,692,916 | as of Jul 31, 2026 · SCHEDULE 13D |
| Phillip Frost, M.D. and 1 other | 13.90 % | 2,784,719 | as of Aug 3, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Fund shareholders of COCRYSTAL PHARMA INC". https://titelia.com/en/stocks/cocrystal-pharma-inc-US19188J4094